|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.86 USD | +0.73% |
|
+7.57% | +1.53% |
| 07:35am | Zai Lab Receives EU Orphan Drug Designation for Lung Cancer Drug | MT |
| 06-10 | Asian Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 33.3 | +87.84% | 12 | ||||||
| 833.31 | +35.5% | 28 | ||||||
| 288.95 | +11.48% | 19 | ||||||
| 2,096,122.22 | +57.37% | 23 | ||||||
| 96.81 | +29.52% | 16 | ||||||
| 220.13 | +10.82% | 30 | ||||||
| 43.3 | -16.94% | 20 | ||||||
| 109.09 | +6.97% | 23 | ||||||
| 101.64 | +51.86% | 26 | ||||||
| 471.67 | +8.43% | 12 | ||||||
| 102.71 | +51.05% | 23 | ||||||
| 275.28 | +8.63% | 21 | ||||||
| 464,000 | +32.95% | 5 | ||||||
| 87.85 | +57.85% | 26 | ||||||
| 322.78 | -0.61% | 9 | ||||||
| 14.52 | +59.78% | 12 | ||||||
| 31.4 | +112.54% | 10 | ||||||
| - | - | 40.3 | +42.1% | 1 | ||||
| - | - | 89.17 | +58.67% | 1 | ||||
| 71.1 | -11.99% | 10 | ||||||
| Average | 128,167.78 | +34.69% | 16 | ||||||
| Weighted average by Cap. | 234,721.01 | +27.97% | 21 |
- Stock Market
- Stocks
- ZLAB Stock
- Sector Zai Lab Limited
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
